These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10772814)

  • 1. Requirement of regulated activation of Ras for response of MDCK cells to hepatocyte growth factor/scatter factor.
    Terauchi R; Kitamura N
    Exp Cell Res; 2000 May; 256(2):411-22. PubMed ID: 10772814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
    Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HGF/SF-induced spreading of MDCK cells correlates with disappearance of barmotin/7H6, a tight junction-associated protein, from the cell membrane.
    Muto S; Sato Y; Umeki Y; Yoshida K; Yoshioka T; Nishikawa Y; Nakamura T; Mori M; Koyama K; Enomoto K
    Cell Biol Int; 2000; 24(7):439-46. PubMed ID: 10875891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells.
    Singh AB; Tsukada T; Zent R; Harris RC
    J Cell Sci; 2004 Mar; 117(Pt 8):1365-79. PubMed ID: 14996914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
    Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor.
    Zhang KX; Ward KR; Schrader JW
    Mol Cancer Res; 2004 Apr; 2(4):242-55. PubMed ID: 15140946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor.
    Zhu H; Naujokas MA; Park M
    Cell Growth Differ; 1994 Apr; 5(4):359-66. PubMed ID: 8043510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering.
    Tanimura S; Chatani Y; Hoshino R; Sato M; Watanabe S; Kataoka T; Nakamura T; Kohno M
    Oncogene; 1998 Jul; 17(1):57-65. PubMed ID: 9671314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of retinoblastoma family proteins by SV40 T antigen results in creation of a hepatocyte growth factor/scatter factor autocrine loop associated with an epithelial-fibroblastoid conversion and invasiveness.
    Martel C; Harper F; Cereghini S; Noë V; Mareel M; Crémisi C
    Cell Growth Differ; 1997 Feb; 8(2):165-78. PubMed ID: 9040938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural Wiskott-Aldrich syndrome protein is involved in hepatocyte growth factor-induced migration, invasion, and tubulogenesis of epithelial cells.
    Yamaguchi H; Miki H; Takenawa T
    Cancer Res; 2002 May; 62(9):2503-9. PubMed ID: 11980641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth Factor/Scatter factor (HGF/SF) is a regulator of fibronectin splicing in MDCK cells: comparison between the effects of HGF/SF and TGF-beta1 on fibronectin splicing at the EDA region.
    Inoue T; Nabeshima K; Shimao Y; Koono M
    Biochem Biophys Res Commun; 1999 Jun; 260(1):225-31. PubMed ID: 10381371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor and Madin-Darby canine kidney cells: in vitro models of epithelial cell movement and morphogenesis.
    Balkovetz DF
    Microsc Res Tech; 1998 Dec; 43(5):456-63. PubMed ID: 9858342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells.
    Fafeur V; Tulasne D; Quéva C; Vercamer C; Dimster V; Mattot V; Stéhelin D; Desbiens X; Vandenbunder B
    Cell Growth Differ; 1997 Jun; 8(6):655-65. PubMed ID: 9185999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S; Meng Q; Laterra JJ; Rosen EM
    Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA; Merlino G
    Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential requirement of Grb2 and PI3-kinase in HGF/SF-induced cell motility and tubulogenesis.
    Royal I; Fournier TM; Park M
    J Cell Physiol; 1997 Nov; 173(2):196-201. PubMed ID: 9365521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.
    Cacci E; Salani M; Anastasi S; Perroteau I; Poiana G; Biagioni S; Augusti-Tocco G
    J Neurosci Res; 2003 Dec; 74(5):760-8. PubMed ID: 14635227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation.
    Nakamura T; Kanda S; Yamamoto K; Kohno T; Maeda K; Matsuyama T; Kanetake H
    Oncogene; 2001 Nov; 20(52):7610-23. PubMed ID: 11753639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA; Merlino G
    Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.